Navigation Links
Inclinix, Inc. Announces Executive Management Team Changes
Date:2/22/2008

WILMINGTON, N.C., Feb. 22 /PRNewswire/ -- Inclinix, Inc., an enrollment contract research organization (CRO) and provider of clinical trial recruitment solutions, announced today the following changes to its executive management team:

-- Steven M. Agnoff, has joined the company in the position of Vice

President of Marketing and Product Management. In this role, Mr. Agnoff

provides strategic direction to the corporate marketing and product

marketing functions of the company and oversees product management

efforts. Prior to joining Inclinix, Mr. Agnoff held executive

leadership and business development roles with organizations including

PDI, Inc., PharmaKon, Fenner PLC, Efson, Inc. and Interroll

Corporation.

-- Daniel D. Marks, has joined the company as Vice President of Corporate

Development. In this role, Mr. Marks is responsible for the evaluation

and execution of Inclinix's strategic investments, joint ventures and

acquisitions. Before joining Inclinix, he held executive management

roles within the technology and medical services sectors.

-- Jeffrey L. Bagshaw, has been named Senior Vice President of Sales. In

this role, Mr. Bagshaw is responsible for leading sales operations of

Inclinix. Prior to this role, he served as vice president of medical

marketing and communications at Inclinix. Prior to joining Inclinix,

Mr. Bagshaw held sales and marketing leadership roles at organizations

including Hoffman La Roche, Bristol Myers Squibb and Exact Sciences.

Newly-reporting to Mr. Bagshaw is:

-- Susan A. Jalbert, who has joined the company as Director of North

American Sales. In this role, Ms. Jalbert has responsibility for

managing strategic client relationship development and tactical sales

efforts with Inclinix's expanded sales team. Prior to joining

Inclinix, Ms. Jalbert held sales and business development leadership

positions at Medidata Solutions, Relsys International, Inc., Domain

Pharma Corporation, Neuromedical Systems, Inc. and the Corning

Nichols Institute. Now reporting to Ms. Jalbert are:

- Ashley Amstutz, sales executive;

- Jeffrey Cazeault, sales executive;

- Svetlana Gorodetsky, sales executive;

- Matt Granger, sales executive;

- Askold Kozbur, sales executive;

- Tom McCollum, senior sales executive;

- Stephen Scaldaferri, sales executive; and

- Christine Ward, sales executive.

CEO and President J. Tobin Geatz said: "We are excited to have these accomplished industry professionals on board to strengthen our leadership team. Having previously helped other innovative companies accelerate their revenues and growth paths, these executives, without doubt, are equipped and ready to guide Inclinix during this time of tremendous growth."

About Inclinix

Founded in 1999, Inclinix, Inc., is the industry's Enrollment CRO. Inclinix's IQM(TM) Intelligent Enrollment process uses technology to amplify traditional services and is proven to accelerate trials for pharmaceutical, biotechnology and medical-device organizations. In addition to its clinical research-related offerings, Inclinix provides strategic medical marketing communications and adherence services to the healthcare industry. For more information on Inclinix, visit http://www.inclinix.com


'/>"/>
SOURCE Inclinix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HCA Announces Preliminary Results for Its Debt Tender Offer
2. STAAR Surgical Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
3. Air Methods Announces New Chief Operating Officer
4. Pacific Fertility Center Announces Breakthrough in Egg Freezing Technology
5. Neurochem announces departure of two members of management team
6. Emergency Dentist 24/7(TM) Announces Worldwide Licensing Program
7. LCA-Vision Announces Quarterly Dividend Payment
8. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
9. China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results
10. IDM Pharma Announces Compliance With NASDAQ Minimum Bid Price Requirements
11. Derma Sciences Announces Several Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming APWCA Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... With a ... medical and food industries. Aside from its GMP accreditation, Validation Center is also ... successfully certified products, services and staff. , Validation Center is ISO17025 accredited and ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways ... and Sausage Council (NHDSC) suggests that Americans prefer their dogs straight off the grill. ... say grilling is their favorite way to cook a hot dog, far outpacing other ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
(Date:5/26/2016)... Georgia (PRWEB) , ... May 26, 2016 , ... ... certificate in intellectual property (IP) to its specialty academic programs. , Answering to ... the college’s existing certificate programs in health law, and environmental and land use ...
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, Hope For Heroes ... lives in military battle for the country. The nonprofit Hope For Heroes partnered ... programs that empower independence for disabled military veterans, as well as police, firemen, and ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... York , May 26, 2016 ... Research "Medical Waste Management Market - U.S. Industry Analysis, Size, ... waste management market in the U.S. was valued at US$ ... a CAGR of 3.4% from 2015 to 2023 to reach ... exhaustive analysis of current and emerging needle free drug delivery ...
(Date:5/25/2016)... , May 25,2016 ... the near-infrared Cellvizio platform for urological and surgical ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal ... regulatory milestone in the US with the 12 ... and Drug Administration (FDA). This new FDA clearance ...
(Date:5/25/2016)... YORK , May 25, 2016  According to ... reached $381 billion in 2015.  Though these are ... plenty of opportunity for success for companies that ... in search of new growth prospects medical device ... on research and development (R&D) than do companies ...
Breaking Medicine Technology: